These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 12466965)

  • 1. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
    Chesire DR; Isaacs WB
    Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
    Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
    Zhu H; Mazor M; Kawano Y; Walker MM; Leung HY; Armstrong K; Waxman J; Kypta RM
    Cancer Res; 2004 Nov; 64(21):7918-26. PubMed ID: 15520198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
    Hu MC; Rosenblum ND
    Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
    Dihlmann S; Siermann A; von Knebel Doeberitz M
    Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N; Spiegelman VS
    Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
    Truica CI; Byers S; Gelmann EP
    Cancer Res; 2000 Sep; 60(17):4709-13. PubMed ID: 10987273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
    Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
    Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
    Feng Y; Lee N; Fearon ER
    Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
    Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
    Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
    Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.
    Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM
    Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation.
    Naishiro Y; Yamada T; Takaoka AS; Hayashi R; Hasegawa F; Imai K; Hirohashi S
    Cancer Res; 2001 Mar; 61(6):2751-8. PubMed ID: 11289158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
    Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
    J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.